Voices
Dario Trapani: Elisabeth de Vries on the Limited Uptake of Biosimilars and Generics in LMICs
Dario Trapani and Elisabeth de Vries/X

Dario Trapani: Elisabeth de Vries on the Limited Uptake of Biosimilars and Generics in LMICs

Dario Trapani, Medical Oncologist at IEO European Institute of Oncology, shaped on X:

“Elisabeth de Vries on access to biosimilars and generics of cancer medicines, showing limited uptake in LMICs and persistent inefficiency in health spending ESMO.

Find related Kerstin Noëlle Vokinger’s latest work on WHO EML:

Title: Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study

Authors: Kerstin Noelle Vokinger, Simon Hediger, Raffaella Casolino, Dario Trapani, Elisabeth G. E. de Vries

Dario Trapani: Elisabeth de Vries on the Limited Uptake of Biosimilars and Generics in LMICs

You may also find this interesting:

Where to Take the Best Breaks at ESMO Congress 2026: Coffee, Sweets, and a Little Fun

Dario Trapani: Elisabeth de Vries on the Limited Uptake of Biosimilars and Generics in LMICs

 

 

Dario Trapani Elisabeth De Vries Elisabeth G.E. de Vries ESMO2026 Kerstin Noelle Vokinger Raffaella Casolino Simon Hediger